Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ambu Regulatory Filings 2020

Mar 18, 2020

3353_rns_2020-03-18_2e8810c6-d4c1-4ef3-8be0-c1ee93aab29e.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Ambu
ideas that work for life

img-0.jpeg

Ambu's production exempt from Malaysian movement control order

The Malaysian authorities have granted Ambu – as a manufacturer of medical devices – exemption from the two-week movement control order that has been declared with effect from 18 March, 2020. The nationwide movement control order is an initiative to counter the spread of Covid-19 in Malaysia.

"Our role is to keep supplying hospitals around the globe with devices that help save lives and improve patient care. With the current pressure on national healthcare systems, we do our utmost to make sure that we can keep producing and delivering supplies to hospitals. Therefore, it is positive that the Malaysian authorities recognize the role we play in supporting healthcare facilities," says Juan Jose Gonzalez, CEO of Ambu.

Contacts

Investors

Michael Højgaard, CFO, tel. +45 4030 4349, email: [email protected]

Nicolai Thomsen, Investor Relations Manager, tel. +45 2620 8047, email: [email protected]

Media

Mikkel Trier Wagner, Director Corporate Communications, tel. +45 4191 0830, email: [email protected]

Ambu A/S

Baltorpbakken 13, 2750 Ballerup, Denmark

Tel. +45 7225 2000, CVR no.: 63 64 49 19

www.ambu.com

About Ambu

Ambu has been bringing the solutions of the future to life since 1937. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia, and patient monitoring & diagnostics solutions. The manifestations of our efforts have ranged from early innovations like the Ambu® Bag™ resuscitator and the Ambu® BlueSensor™ electrodes to our newest landmark solutions like the Ambu® aScope™ – the world's first single-use flexible endoscope. Moreover, we continuously look to the future with a commitment to deliver innovative quality products that have a positive impact on the work of doctors, nurses and paramedics. Headquartered near Copenhagen in Denmark, Ambu employs approximately 3,000 people in Europe, North America and the Asia Pacific. For more information, please visit ambu.com.

Ambu

Company announcement no. 8 2019/20

18 March 2020